Literature DB >> 21599498

The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective.

Macit Ilkit1, Ahmet Baris Guzel.   

Abstract

Vulvovaginal candidosis (VVC) is the second most common cause of vaginitis after bacterial vaginosis, and it is diagnosed in up to 40% of women with vaginal complaints in the primary care setting. Reliable diagnosis of VVC requires a correlation of clinical features with mycological evidence. The mycological methods used for diagnosis include microscopic examination, fungal culture, and antigen tests. Fungal culture can reveal the species of organism(s) responsible for the infection and provide epidemiological data. This report reviews current knowledge about the available diagnostic methods and tests that accurately diagnose VVC, and highlights the importance of fungal culture.

Entities:  

Mesh:

Year:  2011        PMID: 21599498     DOI: 10.3109/1040841X.2011.576332

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  31 in total

1.  Interactions among urogenital, intestinal, skin, and oral infections in pregnant and lactating Panamanian Ngäbe women: a neglected public health challenge.

Authors:  Doris González-Fernández; Kristine G Koski; Odalis Teresa Sinisterra; Emérita Del Carmen Pons; Enrique Murillo; Marilyn E Scott
Journal:  Am J Trop Med Hyg       Date:  2015-03-30       Impact factor: 2.345

2.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

3.  Genotyping reveals no link between Candida albicans genotype and vaginitis severity in Turkish women.

Authors:  Ahmet Barış Güzel; Aylin Döğen; Merve Aydın; Ayşe Serin; Mehmet Sami Serin; Ayşe Kalkancı; Macit Ilkit
Journal:  Mycopathologia       Date:  2013-04-02       Impact factor: 2.574

4.  Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.

Authors:  Deize Evangelista Araújo; Amanda Alves de Oliveira; Mirlane Dos Santos Cabral; Adelaide Fernandes Costa; Bárbara Carolina Silva; Lívia do Carmo Silva; Liliana Borges de Menezes; Célia Maria de Almeida Soares; Andre Correa Amaral; Maristela Pereira
Journal:  Braz J Microbiol       Date:  2020-07-08       Impact factor: 2.476

Review 5.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Vulvovaginal candidiasis in pregnancy.

Authors:  T J Aguin; J D Sobel
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

7.  Associations between bacterial vaginosis, candida vaginitis, trichomonas vaginalis, and vaginal pathogenic community in Chinese women.

Authors:  Dandan Yuan; Wen Chen; Junjie Qin; Dongqian Shen; Youlin Qiao; Beihua Kong
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.

Authors:  Soledad Gamarra; Susana Morano; Catiana Dudiuk; Estefanía Mancilla; María Elena Nardin; Emilce de Los Angeles Méndez; Guillermo Garcia-Effron
Journal:  Mycopathologia       Date:  2014-07-09       Impact factor: 2.574

9.  The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis.

Authors:  Yuanting Tang; Fan Yu; Lairong Huang; Zhengqiang Hu
Journal:  J Clin Lab Anal       Date:  2018-08-12       Impact factor: 2.352

10.  Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.

Authors:  Do Ngoc Anh; Dao Nguyen Hung; Tran Viet Tien; Vu Nhat Dinh; Vu Tung Son; Nguyen Viet Luong; Nguyen Thi Van; Nguyen Thi Nhu Quynh; Nguyen Van Tuan; Le Quoc Tuan; Nguyen Duy Bac; Nguyen Khac Luc; Le Tran Anh; Do Minh Trung
Journal:  BMC Infect Dis       Date:  2021-06-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.